Post Categories
QPS Tapped for Two New FIH Studies
May 5, 2017
Two companies have just selected QPS Netherlands to conduct their First-in-Human studies. Acticor Biotech, a Paris-based biotechnology company focused on the treatment of acute…
QPS Study Shows Estetrol Promising for Prostate Cancer Treatment
May 2, 2017
An investigation into the efficacy and safety of Estetrol (E4) for potential use in the treatment of advanced prostate cancer demonstrated decreased testosterone levels…
QPS Sponsors Day 1 of World ADC Meeting in Berlin
February 20, 2017
QPS is the main sponsor of the Analytical and Bioanalytical Day at the 7th World ADC Meeting, February 20 – 22, 2017 at the…
QPS Assay Finder Database Grows 47 New Assays!
November 28, 2016
For all you assay aficionados out there, we thought you’d be juiced to know — we just added a whopping 47 new assays to…
Client Feedback — Our Gold Standard
December 13, 2016
At QPS, we love making customers happy. Here’s what two of them had to say about our work in DMPK protein binding studies: First…
QPS Is Eastern Minority Supplier Development Council (EMSDC) 2016 Class IV Supplier of the Year
December 5, 2016
For outstanding performance including growth in sales, continuous growth in minority business to minority business purchases, innovation in the delivery of services, significant and…
Sanjay Mitter new VP and Global Head of Clinical Research Services
September 14, 2016
Mr. Sanjay Mitter joined QPS as VP and Global Head of Clinical Research Services. He is currently responsible for Clinical Research, i.e. global pharmacokinetics,…
Let’s Talk Neuro at the AAIC 2016 in Toronto, Canada, July 24-27, 2016
July 19, 2016
Join us from July 24-27, 2016 in Toronto, Canada for the Alzheimer’s Association International Conference. QPS neuroscientists will attend the AAIC 2016 and would…
QPS Netherlands scientist Daniel Wilffert nominated for New Investigator Award by Bioanalysis Zone!
June 22, 2016
Since 2012, a New Investigator Award has been given annually to honor excellence among bioanalytical scientists within their first five years in the industry….
We are exhibiting at the DIA 2016 Annual Meeting at our booth #1200 between June 26-30 at Philadelphia, PA, USA.
June 21, 2016
We are exhibiting at the DIA 2016 Annual Meeting at our booth #1200 between June 26-30 at Philadelphia, PA, USA. If you are attending…
Ben Chien is an EY Entrepreneur Of The Year® 2016 Finalist for Greater Philadelphia!
May 17, 2016
QPS CEO Ben Chien has made it through to the round of 30 (31, actually) being considered for this year’s prestigious EY Entrepreneur Of…
Another CRO Leadership Award! For Compatibility, Expertise, Quality and Reliability
May 17, 2016
Each year, Life Science Leader honors CROs that are the top performers in Compatibility, Capabilities, Expertise, Quality, and Reliability. To determine the winners, the…
Can Nasal Vaccines Confer Sterilizing Immunity?
October 26, 2022
A COVID-19 vaccine that provides sterilizing immunity may be in our future – and with it, a potential light at the end of the…
Evaluating the Costs and Benefits of COVID Lockdowns
October 24, 2022
In the wake of the economic and human costs of the COVID-19 pandemic and governments’ responses to the virus, researchers have tried to evaluate…
FDA Sanctions First Interchangeable Biosimilar Sans Switching Study
October 17, 2022
In August 2022, the Food and Drug Administration (FDA) approved Cimerli™ (ranibizumab-eqrn) as a biosimilar for Lucentis® (ranibizumab). In a time when high prescription…
Amid Polio Outbreaks Around the World, Public Health Leaders Continue to Sound the Alarm
October 10, 2022
“Polio anywhere is a risk to people everywhere.” This public health mantra gets to the root of the problem. Polio remains endemic in Afghanistan…
Lymphatic Delivery Offers Potential Perks for Kinase Inhibitors and Other Cancer Drugs
October 3, 2022
A potential new cancer drug delivery method — through the gut’s lymphatic system rather than blood vessels — could improve treatment outcomes and reduce…
Burden of Disease by Social Status
September 28, 2022
Inequality in the United States has never been more apparent, especially in the wake of the COVID-19 pandemic. In a time when higher income…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
